Literature DB >> 16434562

Role of buprenorphine in the management of heroin addiction.

Soojin Sung1, John M Conry.   

Abstract

OBJECTIVE: To review buprenorphine and explore its role in the treatment of heroin dependence. DATA SOURCES: Articles were identified through a search of MEDLINE (1966-February 2005) using the key terms buprenorphine, heroin, opioid, addiction, and methadone. DATA SYNTHESIS: Buprenorphine appears to provide potential advantages over methadone. Two Cochrane meta-analyses were evaluated on the use of buprenorphine in opioid dependence-one in the management of opioid dependence and the other in the management of opioid withdrawal.
CONCLUSIONS: Buprenorphine offers several advantages for the treatment of heroin addiction. As maintenance treatment, buprenorphine is effective, but not more effective than methadone. In the management of opioid withdrawal, buprenorphine may be better tolerated than clonidine or methadone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434562     DOI: 10.1345/aph.1G276

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  8 in total

1.  Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments.

Authors:  L Cordonnier; M Sanchez; B P Roques; F Noble
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

2.  Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes.

Authors:  Loreto Carvallo; Lillie Lopez; Fa-Yun Che; Jihyeon Lim; Eliseo A Eugenin; Dionna W Williams; Edward Nieves; Tina M Calderon; Carlos Madrid-Aliste; Andras Fiser; Louis Weiss; Ruth Hogue Angeletti; Joan W Berman
Journal:  J Immunol       Date:  2015-02-25       Impact factor: 5.422

Review 3.  Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.

Authors:  Chloe J Jordan; Jianjing Cao; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-04-19       Impact factor: 5.250

4.  Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study.

Authors:  Zheng Yang; Yong-cong Shao; Shi-jiang Li; Jian-lin Qi; Mei-jie Zhang; Wei Hao; Guo-zhang Jin
Journal:  Acta Pharmacol Sin       Date:  2008-07       Impact factor: 6.150

Review 5.  Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.

Authors:  Matias Jaureguiberry-Bravo; Rebecca Wilson; Loreto Carvallo; Joan W Berman
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

6.  Substitution treatment for opioid addicts in Germany.

Authors:  Ingo Ilja Michels; Heino Stöver; Ralf Gerlach
Journal:  Harm Reduct J       Date:  2007-02-02

7.  Retention of patients in opioid substitution treatment: A systematic review.

Authors:  Aisling Máire O'Connor; Gráinne Cousins; Louise Durand; Joe Barry; Fiona Boland
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

8.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.